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ABSTRACT 
Background: The prevalence of functional gastrointestinal disorders (FGIDs) including 
functional dyspepsia (FD), irritable bowel syndrome (IBS) and functional constipation (FC) was 
not studied in Sudan.  
Objectives: The aim of this study is to estimate prevalence of these disorders in Sudanese 
university students using Rome III criteria. 
Materials and Methods: A cross-sectional descriptive study was conducted among medical 
students in Omdurman Islamic University during the period from January to June 2012. The 
selected volunteers responded to a self-reported questionnaire based on Rome III criteria. 
Results: A total of 348 subjects were studied. Male: Female ratio was 0.6: 1. Prevalence of FD, 
IBS and FC were 21.6%, 12.9% and 10.3% respectively. IBS was more prevalent in females 
(16.4%) compared to males (7%). The most prevalent symptoms were postprandial fullness 
(74.1%), straining during ≥25% of defecation (43.9%) and lumpy or hard stools in ≥25% of 
defecations (37%). 
Conclusion: Functional gastrointestinal disorders are common in university students. Further 
studies are needed to characterize the epidemiology of FGIDs in Sudan. 
Key words: Functional gastrointestinal disorders, dyspepsia, irritable bowel syndrome, 
constipation, Sudan. 
 
unctional gastrointestinal disorders 
(FGID) are variable combinations of 
chronic or recurrent gastrointestinal 
symptoms not explained by structural or 
biochemical abnormalities1.  They include 
functional esophageal disorders (e.g. 
functional heartburn and functional 
dysphagia), functional gastro-duodenal 
disorders (e.g. functional dyspepsia (FD)), 
and functional bowel disorders (e.g.  
functional bloating (FB), irritable  Bowel  
syndrome (IBS), functional constipation 
(FC), functional  diarrhea (FD),  and 
unspecified functional bowel disorders (U-
FBD). These disorders are very common 
worldwide2 affecting patients’ quality of 
life and causing significant reduction in 
work productivity and increased economic 
burden3-5.  
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It is recommended that certain "red flag" 
symptoms can be used to distinguish 
FGIDs from structural intestinal diseases6. 
These include drastic weight loss, a 
history of organic bowel disease, a 
history of digestive surgery, blood in 
stool, awakening due to abdominal pain 
during night, anemia, fever or arthralgia. 
According to the Rome III criteria, the 
latest symptom-based   classification   
system   for  FGIDs,   onset   of  
functional   gastrointestinal symptoms  
should  start at  least  6  months before 
clinical  presentation  and  the diagnostic 
criteria must be fulfilled for the last 3 
months6,7. 
There are no definitive clinical findings or 
specific biomarkers that characterize 
FGIDs. Symptoms are the main causes 
that bring patients to clinicians. Some of 
the disorders are very common whereas 
others are very rare; however, prevalence 
varies from one country to another. 
Functional dyspepsia is the most common 
F 
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gastro-duodenal disorder8, with dyspeptic 
patients frequently seen in out-patient 
clinics.  Patients frequently complain of 
upper abdominal discomfort, postprandial 
fullness or early satiation. According to 
Rome III criteria, FD is further divided 
into two subgroups: epigastric pain 
syndrome (EPS) and postprandial distress 
syndrome (PDS). On the other hand, 
abdominal bloating, with or without 
distension, is a common symptom 
especially in patients with IBS and 
constipation. In IBS, patients complain of 
excessive gas (flatulence), frequent burping 
(eructation), and abdominal rumbling 
(borborygmi). Irritable bowel syndrome is 
one of the commonest gastrointestinal 
conditions encountered in primary or 
secondary care. The disorder is more 
common in young people, especially 
women. Although symptoms (e.g. 
diarrhea, constipation, bloating, and pain) 
may overlap across FGID, IBS is more 
specifically defined as pain associated with 
change in bowel habit. The change in 
bowel habit can be constipation-
predominant or diarrhea-predominant; 
however, some patients present with 
mixture between the two. The diagnosis 
should be reached using symptom based 
clinical criteria rather than excluding 
underlying organic disease by exhaustive 
investigation9. Constipation is a common, 
often chronic, disorder of   gastrointestinal   
motility with   a high   prevalence.  In   
functional constipation, patients often 
experience constipation in association with 
other symptoms like infrequent  bowel  
movements,  hard  or  lumpy  stools,  
straining,  bloating,  a  feeling  of 
incomplete evacuation after a bowel 
movement and abdominal discomfort1. 
These symptoms are also shared by patients 
with constipation- predominant irritable 
bowel syndrome (IBS-C). 
There is paucity of data regarding prevalence 
of FGIDs in Sudan.  On the other hand, 
familiarity of physicians with the term is 
unknown.  In a survey within the Asia-
Pacific region, only 40% of practitioners were 
familiar with the term FD and even less had 
heard about Rome criteria10. This study 
aimed to determine the pattern of selected 
functional gastrointestinal disorders (FD, IBS 
and FC) in Sudanese university students 
using Rome III criteria. 
MATERIALS AND METHODS: 
The study was conducted in Omdurman 
Islamic University during the period from 
January to June to 2012. All students in 
the Faculty of Medicine were approached. 
All candidates enrolled  in  the  study  were  
subjected  to  full  medical  history  and  
thorough  clinical examination. Those with a 
structural problem in the gastrointestinal tract, 
pregnancy, fever, weight loss or 
gastrointestinal bleeding were excluded. A 
total of 348 medical students were selected to 
participate in the study. Each student 
responded to a questionnaire based on Rome 
III criteria to identify functional dyspepsia 
(FD), irritable bowel syndrome (IBS) and 
functional constipation (FC). Other types of 
FGIDs were not included in our study. 
Symptoms tested in the questionnaire 
included postprandial bloating, early satiety, 
abdominal pain relieved with defecation , 
abdominal pain associated with stool 
frequency or form, straining during at least 
25% of defecation, feeling of incomplete 
evacuation, using manual maneuver to aid 
defecation, lumpy or hard stools in at least 
25% of defecations and less than 3 motions 
per week. Criteria were fulfilled for the last 3 
months with symptom onset at least 6 months 
prior to time of study. 
RESULTS: 
A total of 348 subjects were included in the 
study, 129 (37%) were males and 
219(63%) were females. Their ages ranged 
from 22 to 27 years old with a mean age of 
23.5. Table 1 shows distribution of 
gastrointestinal symptoms among males 
and females in the study group. The most 
prevalent symptoms were post prandial 
fullness in 258(74.1%), straining during 
≥25% of  defecation  in  153(43.9%),  
lumpy  or  hard  stools  in  129(37%)  and  
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abdominal  pain associated with stool 
frequency in 108(31%). Table 2 presents 
percentages of the studied FGIDs among 
the medical students. A total of 75(21.5%) 
had functional dyspepsia, 45(12.9%) had 
irritable bowel syndrome and 36(10.3%) 
had functional constipation. IBS was more 
prevalent among females 36(16.4%) 
compared to males 9(7%). 








Postprandial fullness 111(31.9) 147(42.2) 258 
(74 1) 
Early satiety 
42(12.1) 27(7) 69(19.1) 
 
Abdominal pain associated with stool frequency 
39(11.2) 69(19.8) 108(31) 
 
Abdominal pain associated with changes in stool 
form 
30(8.6) 66(18.9) 96(27.5) 
Abdominal pain relieved with defecation 18(5.2) 60(17.2) 78(22.4) 
Straining during ≥25% of defecation 69(19.8) 84(24.1) 153(43.9) 
Feeling  of  incomplete  evacuation  after  bowel 
movement 
33(9.5) 45(12.9) 78(22.4) 
Sensation that stools cannot be passed at bowel 
movement 
0.0(0.0) 3(0.8) 3(0.8) 
Hard stools in ≥25% of defecations 48(13.8) 81(23.2) 129(37) 
Manual maneuver used  during defecation 15(4.3) 36(10.3) 51(14.6) 
Motions < 3 per week 18(5.1) 30(8.6) 48(13.7) 
    
DISCUSSION: 
The diagnosis of a functional 
gastrointestinal disorder is based on 
utilization of Rome criteria through 
administration of self-reported 
questionnaire. The Rome criteria have been 
evolving since 1990 (Rome classification 
system for FGIDs) until 2006 (Rome III 
criteria)6,7. Since that time, they have been 
applied for diagnosis of FGIDs in many 
countries worldwide; however, there is 
paucity of data regarding their use in 
Sudan. 
Functional dyspepsia is the commonest 
cause of dyspeptic symptoms in upper 
abdomen8. About one fifth (21.6%) of our 
study group had functional dyspepsia. 
Difference between males and females was  
insignificant. Previous studies showed 
prevalence of 8-23%11-13. The classification 
of functional dyspepsia into epigastric pain 
syndrome (EPS) and postprandial distress 
syndrome (PDS) was not investigated. On 
the other hand, the pathophysiology of 
functional dyspepsia is still under 
investigation. 
Prevalence of irritable bowel syndrome 
varies considerably between countries. It 
ranges from as low as 5% in Asia14 to 
higher rates in Western countries; however 
the global map of IBS is far  from  
complete  since  community-based  
prevalence  data  is  not  available  from  
many areas15. The percentage in our study 
was 12.9%. Percentage of females 
affected was more than twice that of
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Functional dyspepsia 27 (20.9) 48 (21.9) 75 (21.6) 
Irritable bowel syndrome 9 (7.0) 36 (16.4) 45 (12.9) 
Functional constipation 12 (9.3) 24 (11.0) 36 (10.3) 
Healthy 81 (62.8) 111 (50.7) 192 (55.2) 
Total 129 (100) 219 (100) 348 (100) 
 
males. Similarly, many previous studies 
reported higher percentages of IBS in 
females16,17. It has been suggested that the 
gender difference might be due to 
difference between males and females in 
their responses to stress or in effects of 
their sex hormones on the gastrointestinal 
tract18.  In addition, a number of risk 
factors including anxiety and depression 
were found to be associated with IBS19. 
Since medical students are exposed to 
repeated anxiety and stressful conditions 
during their course of study, they are 
expected to have higher prevalence of IBS 
than the general population. In a previous 
study conducted in Mexico, prevalence of 
IBS among university students was higher 
than professors and other employees in the 
same universities20.  Further studies are 
needed to investigate association of IBS 
with these risk factors in the future. It is 
worth noting that the impact of IBS on 
health related quality of life is very high. It 
may be higher than the impact of many 
chronic diseases including asthma4. 
Constipation is a major public health 
problem. It is shared between functional 
constipation and constipation-predominant 
IBS. Other symptoms like incomplete 
evacuation, hard stools, straining and 
relieve of abdominal pain with defecation 
help to differentiate between the two. 
About 10% of our medical students suffer 
from functional constipation. A higher 
prevalence was reported among university 
students in other countries20. In our study, 
the most dominant symptoms of FC were 
straining and hard stools. These were the 
same dominant symptoms reported in other 
studies21. Although the clinical presentation 
is somewhat different between functional 
constipation and constipation-predominant 
IBS, their burden on health and quality of 
life were found to be similar21. It is worth 
noting that, in the absence of a physician 
exclusion of organic disease, Rome III 
criteria may potentially include some 
patients with pathologic disorders in 
addition to those with true functional 
disorders22. 
One of the major limitations in this study is 
the translation of Rome III questionnaire 
from English to Arabic. In addition, the 
questionnaire was not previously validated 
for diagnosis of FGIDs in Sudan. However, 
researchers were available during the process 
of data collection to  explain  questionnaire  
items  and  to  answer  students’  questions  
about  the  symptoms. Another limitation is 
the selection bias in the study population. 
However, this study shows that FGIDs are 
common among university students. Further 
studies are needed to measure prevalence of 
FGIDs in the general population and to 
investigate their associations with risk factors 
like diet, exercise, anxiety, stress and 
depression. 
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